Obesity

Healio is continuing its partnership with the Cardiometabolic Health Congress in support of the 17th Annual Cardiometabolic Health Congress: The Present and Future of Cardiometabolic Health in Boston.

Patients with cancer and obesity appeared well-represented in clinical trials, indicating that clinical trial findings may be generalizable to this patient population, according to study results published in JAMA Network Open.

Exposure to moderate or high levels of some phthalates is associated with lower levels of sex hormone-binding globulin and a higher risk for obesity among women, according to study data.

Ultraprocessed food intake among mothers was associated with an increased risk for overweight and obesity among their children, according to researchers.

There is substantial heterogeneity in obesity prevalence among subgroups of Asian American adults, according to a recent study published in Annals of Internal Medicine.

Today, Eli Lilly and Company received FDA fast track designation for tirzepatide to treat adults with obesity or overweight with weight-related comorbidities.

A personalized diet that targets postprandial glycemic response led to similar weight loss levels compared with a low-fat diet among adults with obesity and abnormal glucose metabolism, a recent study showed.

The CDC recently announced that it is no longer recommending universal masking in health care settings unless the facility is in an area of high COVID-19 transmission.

Adults with type 2 diabetes and a BMI of 21 kg/m2 to 27 kg/m2 have high likelihood of diabetes remission if they lose 10% of their starting weight, researchers reported.

Healio and the Cardiometabolic Health Congress are proud to partner for the 17th Annual Cardiometabolic Health Congress: The Present and Future of Cardiometabolic Health in Boston this fall.